79 related articles for article (PubMed ID: 8529327)
1. Comparative effects of omeprazole on xenobiotic metabolizing enzymes in the rat and human.
Kashfi K; McDougall CJ; Dannenberg AJ
Clin Pharmacol Ther; 1995 Dec; 58(6):625-30. PubMed ID: 8529327
[TBL] [Abstract][Full Text] [Related]
2. Effect of dietary supplementation with carotenoids on xenobiotic metabolizing enzymes in the liver, lung, kidney and small intestine of the rat.
Jewell C; O'Brien NM
Br J Nutr; 1999 Mar; 81(3):235-42. PubMed ID: 10434850
[TBL] [Abstract][Full Text] [Related]
3. Effects of 5-fluorouracil on the drug-metabolizing enzymes of the small intestine and the consequent drug interaction with nifedipine in rats.
Yoshisue K; Nagayama S; Shindo T; Kawaguchi Y
J Pharmacol Exp Ther; 2001 Jun; 297(3):1166-75. PubMed ID: 11356943
[TBL] [Abstract][Full Text] [Related]
4. Concurrent subacute exposure to arsenic through drinking water and malathion via diet in male rats: effects on hepatic drug-metabolizing enzymes.
Naraharisetti SB; Aggarwal M; Sarkar SN; Malik JK
Arch Toxicol; 2008 Aug; 82(8):543-51. PubMed ID: 18528686
[TBL] [Abstract][Full Text] [Related]
5. Modulation of hepatic and renal drug metabolizing enzyme activities in rats by subchronic administration of farnesol.
Horn TL; Long L; Cwik MJ; Morrissey RL; Kapetanovic IM; McCormick DL
Chem Biol Interact; 2005 Apr; 152(2-3):79-99. PubMed ID: 15840382
[TBL] [Abstract][Full Text] [Related]
6. [Dietary protein as a modulator of the activity of enzymes metabolizing xenobiotics. UDP glucuronosyltransferase and glutathione transferase].
Kravchenko LV; Tutel'ian VA
Vopr Pitan; 1990; (6):64-8. PubMed ID: 2127326
[TBL] [Abstract][Full Text] [Related]
7. Pre- and postweaning development of drug-metabolizing enzyme activities in small intestine and liver of rats.
de Waziers I; Boisset M; Atteba S
Drug Metab Dispos; 1988; 16(2):310-5. PubMed ID: 2898352
[TBL] [Abstract][Full Text] [Related]
8. Sex-specific effects of gestational and lactational coexposure to lead and cadmium on hepatic phase I and phase II xenobiotic/steroid-metabolizing enzymes and antioxidant status.
Pillai P; Patel R; Pandya C; Gupta S
J Biochem Mol Toxicol; 2009; 23(6):419-31. PubMed ID: 20024958
[TBL] [Abstract][Full Text] [Related]
9. [Effects of 18 alpha-glycyrrhizic acid on rat liver cytochrome P450 isoenzymes and phase II transferase].
Yang J; Peng RX; Kong R; Yu JP
Yao Xue Xue Bao; 2001 May; 36(5):321-4. PubMed ID: 12584850
[TBL] [Abstract][Full Text] [Related]
10. Omeprazole coinduces multiple xenobiotic-metabolizing enzymes in the rat.
Kashfi K; Dannenberg AJ
Ann N Y Acad Sci; 1995 Sep; 768():237-42. PubMed ID: 8526355
[No Abstract] [Full Text] [Related]
11. Lansoprazole and ethanol metabolism: comparison with omeprazole and cimetidine.
Battiston L; Tulissi P; Moretti M; Pozzato G
Pharmacol Toxicol; 1997 Dec; 81(6):247-52. PubMed ID: 9444664
[TBL] [Abstract][Full Text] [Related]
12. The effects of mebendazole on P4501A activity in rat hepatocytes and HepG2 cells. Comparison with tiabendazole and omeprazole.
Baliharová V; Skálová L; Maas RF; De Vrieze G; Bull S; Fink-Gremmels J
J Pharm Pharmacol; 2003 Jun; 55(6):773-81. PubMed ID: 12841937
[TBL] [Abstract][Full Text] [Related]
13. Regulation of uridine diphosphate glucuronosyltransferase expression by phenolic antioxidants.
Kashfi K; Yang EK; Chowdhury JR; Chowdhury NR; Dannenberg AJ
Cancer Res; 1994 Nov; 54(22):5856-9. PubMed ID: 7954414
[TBL] [Abstract][Full Text] [Related]
14. Omeprazole alleviates benzo[a]pyrene cytotoxicity by inhibition of CYP1A1 activity in human and mouse hepatoma cells.
Shiizaki K; Ohsako S; Kawanishi M; Yagi T
Basic Clin Pharmacol Toxicol; 2008 Nov; 103(5):468-75. PubMed ID: 18793272
[TBL] [Abstract][Full Text] [Related]
15. [Effect of vitamin A excess and T-2 toxin on the enzyme system activities of the second phase of xenobiotic metabolism in the rat liver].
Kravchenko LV; Kon' IIa; Avren'eva LI; Tutel'ian VA
Vopr Med Khim; 1984; 30(6):88-91. PubMed ID: 6442041
[TBL] [Abstract][Full Text] [Related]
16. Effect of strain and diet upon constitutive and chemically induced activities of several xenobiotic-metabolizing enzymes in rats.
Stott WT; Kan HL; McFadden LG; Sparrow BR; Gollapudi BB
Regul Toxicol Pharmacol; 2004 Jun; 39(3):325-33. PubMed ID: 15135211
[TBL] [Abstract][Full Text] [Related]
17. Impact of gut microbiota on intestinal and hepatic levels of phase 2 xenobiotic-metabolizing enzymes in the rat.
Meinl W; Sczesny S; Brigelius-Flohé R; Blaut M; Glatt H
Drug Metab Dispos; 2009 Jun; 37(6):1179-86. PubMed ID: 19282396
[TBL] [Abstract][Full Text] [Related]
18. Induction of rodent hepatic drug-metabolizing enzyme activities by the novel anticonvulsant remacemide hydrochloride.
Riley RJ; Lambert C; Cooper AE; Richmond H; Hall M; Jordan MC; Logan CJ; Clark B
Drug Metab Dispos; 1995 Sep; 23(9):922-8. PubMed ID: 8565782
[TBL] [Abstract][Full Text] [Related]
19. Effects of benzo[a]pyrene on tissue activities of metabolizing enzymes and antioxidant system in normal and protein-malnourished rats.
Badary OA; AbdEl-Gawad HM; Taha RA; Ali AA; Hamada FM
J Biochem Mol Toxicol; 2003; 17(2):86-91. PubMed ID: 12717740
[TBL] [Abstract][Full Text] [Related]
20. Comparative studies of drug-metabolizing enzymes in dog, monkey, and human small intestines, and in Caco-2 cells.
Prueksaritanont T; Gorham LM; Hochman JH; Tran LO; Vyas KP
Drug Metab Dispos; 1996 Jun; 24(6):634-42. PubMed ID: 8781778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
